Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate

Single-fraction HDR-boosted IMRT is a safe effective method of dose escalation for localized prostate cancer.